Global Bio-chem Technology Group Company Limited
0809.HK · HKSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | HK$2 | HK$1 | HK$0 | HK$1 |
| % Growth | 45.6% | 10,709% | -98.3% | – |
| Cost of Goods Sold | HK$2 | HK$1 | HK$0 | HK$1 |
| Gross Profit | HK$0 | HK$0 | -HK$0 | HK$0 |
| % Margin | 10.9% | 3.2% | -2,072% | 6.5% |
| R&D Expenses | HK$0 | HK$0 | HK$0 | HK$0 |
| G&A Expenses | HK$0 | HK$0 | HK$0 | HK$0 |
| SG&A Expenses | HK$0 | HK$0 | HK$0 | HK$0 |
| Sales & Mktg Exp. | HK$0 | HK$0 | HK$0 | HK$0 |
| Other Operating Expenses | HK$0 | -HK$0 | -HK$0 | HK$0 |
| Operating Expenses | HK$0 | HK$0 | HK$0 | HK$0 |
| Operating Income | -HK$0 | -HK$0 | -HK$0 | -HK$0 |
| % Margin | -7% | -23.2% | -2,122.9% | -49.7% |
| Other Income/Exp. Net | HK$1 | HK$4 | -HK$1 | -HK$0 |
| Pre-Tax Income | HK$1 | HK$4 | -HK$1 | -HK$0 |
| Tax Expense | -HK$0 | -HK$0 | -HK$0 | HK$0 |
| Net Income | HK$1 | HK$4 | -HK$1 | -HK$0 |
| % Margin | 38.5% | 307.5% | -11,352.9% | -53.7% |
| EPS | 0.086 | 0.47 | -0.16 | -0.045 |
| % Growth | -81.7% | 393.8% | -255.6% | – |
| EPS Diluted | 0.086 | 0.47 | -0.16 | -0.045 |
| Weighted Avg Shares Out | 9 | 9 | 9 | 9 |
| Weighted Avg Shares Out Dil | 9 | 9 | 9 | 9 |
| Supplemental Information | – | – | – | – |
| Interest Income | HK$0 | HK$0 | HK$0 | HK$0 |
| Interest Expense | HK$0 | HK$1 | HK$1 | HK$1 |
| Depreciation & Amortization | HK$0 | HK$0 | HK$0 | HK$0 |
| EBITDA | HK$0 | HK$5 | -HK$0 | HK$1 |
| % Margin | 0.8% | 341.6% | -3,690.2% | 105.2% |